MPLT Competitors & Alternatives
Compare MapLight Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MPLT
Main Stock$6.94
-4.28%
Tradestie Score
50
Analyst Upside
+282.4%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Other
Major Customers
0
Diversified enterprise & commercial customer base.
Critical Suppliers
0
Internal vertical integration & multi-sourced components.
Direct Ecosystem Rivals
0
Sole-source / monopoly positioning in sub-sector.
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
+0.64%
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$5.06
-9.65%
|
$422.50M | - | 43 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$11.65
-4.74%
|
$407.71M | - | 52 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$9.94
-5.06%
|
$386.68M | - | 49 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.21
+1.41%
|
$382.04M | - | 31 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.09
-9.64%
|
$371.64M | - | 50 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$8.47
-11.12%
|
$357.51M | - | 28 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$8.42
-4.27%
|
$354.59M | - | 48 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$9.72
-5.45%
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$42.85
-0.37%
|
$353.70M | - | 36 | Compare |
More MPLT Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC None)
218 stocks in this industry